Tag: evidence-based

  • The Science of Menopause by Philippa Kaye: Summary, Key Ideas & Review

    Book in one sentence: A UK GP strips the misinformation out of menopause and replaces it with the actual evidence: hormones, HRT, symptoms, metabolism, and all.



    What Is The Science of Menopause About?

    You ask your doctor about HRT and she says she’s “not really comfortable with it.” You search online and get 457 million results. You find a Facebook group and come away more confused than before. This is the information environment most women are navigating when their bodies start behaving in ways they don’t recognize.

    Dr. Philippa Kaye is a UK GP (general practitioner) and the author of nine books on women’s health. She wrote this one because her consulting room was full of women who didn’t understand what was happening to them, assumed their symptoms were just aging, or were refusing treatments because of clinical trial data from 2002 that was badly misapplied for two decades. The book is structured as a Q&A, so you can open it to “Why am I gaining weight?” or “What is genitourinary syndrome?” and get a direct clinical answer. You can also read it front to back and build a coherent picture of the whole transition.

    At 224 pages, it reads more like a medical briefing than a book. Dense, well-organized, no filler. The tone is what you’d want from a doctor who actually has 30 minutes to talk to you: clear, evidence-grounded, and without an agenda beyond helping you make informed decisions.


    What Does Menopause Actually Do to Your Metabolism?

    This is the section that matters most if weight and eating have been part of your story.

    The average adult gains 1 to 1.5 pounds per year from early adulthood through middle age. That’s not a perimenopause problem specifically. It’s what happens when muscle mass gradually declines with age and nobody replaces it. Muscle burns more calories at rest than fat does, so losing muscle without adding it back creates a slow caloric gap even when nothing else changes. Perimenopause accelerates this process.

    Estrogen also controls where fat gets deposited. As levels fall, fat shifts from the hips and thighs toward the abdomen (visceral fat), and the body simultaneously tries to produce an alternative form of estrogen called estrone from adipose tissue. Visceral fat carries higher metabolic and cardiovascular risk than subcutaneous fat. This is why body composition changes in midlife can feel so different from earlier weight gain (same number on the scale, different distribution, different implications).

    Kaye’s practical recommendation is strength training twice per week as a specific clinical priority, not a general wellness suggestion. The goal isn’t aesthetics. It’s preserving the metabolic engine that’s been quietly losing mass since your thirties. For anyone whose relationship with food and weight has been complicated, this framing is worth sitting with: the changes aren’t a personal failure, and the lever isn’t less food. It’s more muscle.

    “With a lower muscle mass, even if you consume the same amount of food/calories, you will gain weight.” (Philippa Kaye)


    Is HRT Really as Dangerous as Everyone Says?

    The short answer is: the HRT most women are afraid of is not the HRT being prescribed now.

    In the early 2000s, a major US study called the Women’s Health Initiative (WHI) published results suggesting that HRT increased risks of breast cancer and cardiovascular disease. Prescriptions dropped by 50 percent almost overnight. The fear stuck, and it’s still in the room when most women have this conversation with their doctors today.

    Here’s what the coverage got wrong. The average participant in that study was 63 years old. These were not perimenopausal women in their mid-forties. The study also used oral synthetic estrogen and synthetic progestins, formulations that look nothing like what evidence-based practitioners currently prescribe. Kaye walks through the key distinctions:

    • Transdermal estrogen (gel, patch, or spray) bypasses the liver and carries no increased risk of blood clots or stroke. Oral estrogen does carry that risk. Delivery route matters clinically.
    • Micronized progesterone (sometimes called Utrogestan or Gepretix) is body-identical and plant-derived. It carries a much lower breast cancer signal than the synthetic progestins studied in the WHI.
    • Timing matters. HRT started within 10 years of menopause onset may be cardioprotective. Starting much later, in women who already have established cardiovascular disease, carries a different risk profile.

    The WHI findings were real for that population, using those formulations, at those ages. The harm was in applying those conclusions to a completely different group. Kaye doesn’t demonize the researchers. She frames this as a clinical literacy problem, one that has cost women years of unnecessary suffering, bone fractures, and preventable cardiovascular events. Undertreated menopause is its own health crisis, and she makes that case with specifics.

    For women who can’t or don’t want to use HRT, the non-hormonal options get the same rigorous treatment. Fezolinetant (brand name Veoza, FDA-approved 2023) is the first non-hormonal prescription drug specifically targeting the mechanism of hot flashes. SSRIs and SNRIs reduce hot flash frequency by 30 to 60 percent. CBT is clinically validated for hot flashes, insomnia, anxiety, and depression. The book rates each option by evidence quality, which is more useful than a list.


    What About the Symptoms Nobody Talks About?

    Hot flashes get the most airtime, but Kaye explains why they happen in a way most books skip. The hypothalamus keeps body temperature within a narrow range. Estrogen normally moderates a peptide called neurokinin B (NKB). As estrogen falls, NKB overstimulates the thermoregulatory center via NK3 receptors, and the brain reads a temperature emergency that isn’t happening. The body launches its heat-dissipation response: vasodilation, flushing, sweating. Core body temperature doesn’t actually rise. You’re cooling something that isn’t hot. Understanding this mechanism explains why fezolinetant works without hormones: it blocks the NK3 receptor directly.

    Mood symptoms are consistently misidentified. Perimenopausal women are 40 percent more likely to be diagnosed with depression than premenopausal women, and mood changes (anxiety, irritability, low mood, brain fog) often show up before hot flashes do. Women in their mid-forties get put on antidepressants with nobody connecting the symptoms to hormonal fluctuation. Estrogen supports serotonin synthesis and receptor sensitivity; progesterone acts on GABA receptors. As both hormones decline and swing erratically (Kaye’s phrase: “a roller-coaster”), the neurochemical scaffolding for mood stability is progressively removed. HRT can resolve hormonally-driven mood symptoms that antidepressants alone won’t touch.

    Genitourinary syndrome of menopause (GSM) is the symptom with the worst visibility gap. It covers vaginal dryness, painful sex, recurrent UTIs, and urinary urgency, and it affects over half of postmenopausal women. Unlike hot flashes, which often ease over time, GSM is progressive without treatment. Vaginal estrogen is the definitive fix: local application, minimal systemic absorption, safe for most women including breast cancer survivors, reduces UTI frequency by more than 50 percent in studies. It takes three to six months for full effect and should be continued long-term because the condition is chronic. Women don’t report it (stigma, or the assumption that sex is just supposed to hurt now), and clinicians often don’t ask. The silence around GSM costs women years of avoidable suffering that is, in most cases, straightforwardly treatable.


    Is The Science of Menopause Worth Reading?

    Read this if you want one reliable, clinical reference on perimenopause and you’re done wading through wellness influencer content that can’t tell you why hot flashes happen or what micronized progesterone actually is. Kaye treats readers as adults. For anyone who has struggled with weight and wants to understand the metabolic mechanics of this transition (not just “eat less, exercise more”), the muscle mass and fat distribution sections are unusually well-sourced and direct. If you’re on a GLP-1 medication and navigating perimenopause at the same time, the sections on muscle preservation and metabolic rate are directly relevant to how both interventions interact.

    Skip it if you want a diet plan, a step-by-step protocol, or extended personal narrative. This is a reference book. The lifestyle chapter is evidence-grounded but concise: it points to what works and why, without building out full programs. Also worth noting: Kaye is a UK GP, so her treatment recommendations follow NICE guidelines, which sometimes differ from US FDA approvals. The distinctions are flagged in the text, but you’ll need to translate some of it.

    One caveat: The reader rating reflects the fact that some readers found it too dense or too clinical. That’s accurate. It reads like a thorough GP who won’t waste your appointment. Whether that’s a feature or a bug depends entirely on what you showed up for.


    Books Like The Science of Menopause

    BookAuthorBest For
    Menopause BootcampSuzanne Gilberg-LenzA warmer, more lifestyle-forward companion to Kaye’s clinical lens
    The Menopause BrainLisa MosconiGoes deep on the cognitive and neuroprotective angle Kaye covers briefly
    The Great Menopause MythKristin JohnsonFunctional medicine approach, more integrative, less evidence-rigorous
    The Power of HormonesMax NieuwdorpBroader hormonal context, useful for understanding the full endocrine picture
    It’s Your HormonesGeoffrey RedmondUS-focused, clinical, good for understanding HRT formulation options in more depth
  • The Hormone Myth by Robyn Stein DeLuca: Summary, Key Ideas & Review

    Book in one sentence: A health psychologist dismantles fifty years of flawed PMS research, pharmaceutical manipulation, and cultural mythology to argue that hormones are not, for most women, the cause of emotional instability, and that believing they are has real costs.



    What Is The Hormone Myth About?

    Picture the last time you felt frustrated, tired, or short-tempered around someone. Now imagine the response was: “Are you on your period?” The conversation stops. Your point goes unheard. The biology explanation short-circuits everything else, and nothing you were actually responding to gets addressed.

    Robyn Stein DeLuca, a clinical health psychologist at Stony Brook University, spent years in the research literature on exactly this dynamic. What she found was a significant gap between what the science says and what most people believe. Psychologists have known since the early 1990s that women’s emotional stability, measured rigorously over time, is comparable to men’s. That finding has been replicated. It is not obscure. And almost no one knows it.

    The Hormone Myth covers the full arc of women’s reproductive life: menstruation, pregnancy, postpartum, and menopause. At each stage, DeLuca traces the myth’s origins, examines what the actual research shows, and follows the money. Her argument is not that hormonal conditions don’t exist. It is that the real conditions affect a minority of women, and the culture has been applying that minority’s experience to everyone, for reasons that have more to do with profit and ideology than with science.

    What Does the Science Actually Say About PMS?

    The short version: the founding PMS research was built on methods that would not survive peer review today. Five specific failures show up repeatedly across the studies that established PMS as a widespread condition.

    Retrospective reporting. Women were asked to recall past symptoms instead of tracking them in real time. Memory is systematically inflated by expectation. When you prime someone to look for symptoms, they find more of them on recall than they documented at the time.

    No diagnostic standardization. Researchers eventually catalogued over 150 possible PMS symptoms, with no agreed severity threshold and no standard timing window. When your criteria include 150 possibilities, finding the condition “everywhere” is not a discovery. The resulting prevalence estimates ranged from 5% to 97% of all menstruating women (a range that wide is functionally useless).

    No control groups. Most foundational studies recruited women who already identified as having PMS, then confirmed they had PMS symptoms. Without a comparison group, you cannot establish that the symptom rate is elevated. You don’t know the baseline.

    Homogeneous samples. The research was conducted almost entirely on white, middle-class, Western women, then applied universally. PMS symptom reporting varies across cultures in ways that a purely biological condition should not.

    Single-cycle measurement. A genuine syndrome requires cyclical recurrence. Most founding studies assessed one cycle.

    When researchers applied rigorous standards (prospective daily tracking, standardized criteria, multi-cycle confirmation, functional impairment thresholds), the condition refined to PMDD: a real diagnosis affecting 3-8% of menstruating women. Not 50%. Not everyone. A specific minority. The myth applies the minority’s experience to the whole population, and that universalization is where the harm concentrates.

    “A large body of scientific research says that fluctuating reproductive hormones don’t play a major role in women’s mental health, because when women’s emotional stability is measured by the frequency and severity of mood swings they experience over time, it is in fact similar to the stability of men. Surprised? Here’s the kicker: psychologists have known that since the early 1990s but it is probably news to you.” — Robyn Stein DeLuca

    Why Do We Still Believe Hormones Control Women’s Moods?

    A finding this significant should have reshaped the cultural narrative by now. It has not. DeLuca’s most interesting chapter asks why, and the answer involves three separate mechanisms working together.

    The nocebo effect. The nocebo effect is the clinical term for what happens when expecting a negative experience makes it more likely and more severe. Girls are primed to expect menstrual misery before they ever menstruate, through tampon company pamphlets distributed in elementary school, puberty books that describe menstruation as an emotional rollercoaster, and jokes treating menstruating women as irrational. By first period, a girl has absorbed hundreds of messages, from authoritative sources, that she should feel terrible. Research confirms this priming has measurable effects. Expectation of a symptom generates some portion of the symptom. The aggressive negative framing of every stage of women’s reproductive life is not neutral information. It is partly a self-fulfilling loop.

    The pharmaceutical industry. DeLuca documents the manipulation in detail, and the details are not flattering. Robert Wilson’s 1966 book Feminine Forever argued that menopause is an estrogen-deficiency disease and all women should take manufactured estrogen for life. Widely read, excerpted in Vogue, and influential enough to shape a generation of medical practice. What readers did not know: Wilson’s research was funded by Ayerst Laboratories (maker of Premarin), who helped write the book, funded his promotional tour, and secretly purchased enough copies to maintain its bestseller status. The narrative that menopause is a disease was not a scientific finding. It was a marketing campaign. When Eli Lilly’s patent on Prozac expired, they rebranded the same drug as Sarafem in pink-and-lavender packaging for PMDD, then marketed it to the general PMS population (far larger than the 3-8% for whom clinical justification existed). The company that defined the disorder funded the approval research and sold the treatment.

    Social utility. The myth also serves a function for individual women, which makes it harder to discard. Invoking PMS provides a socially acceptable explanation for anger or frustration that would otherwise draw social sanction. “I’m sorry, I’m PMSing” allows a woman to express an emotion without threatening the cultural expectation of perpetual pleasantness. It is a rational adaptation to an irrational environment. The cost is reinforcing the myth that enables the limitation.

    What This Means If You’re Trying to Fix Your Eating

    This is the counterpoint that earns The Hormone Myth a place on this list alongside the hormone-optimization books. A significant portion of the weight and eating advice aimed at women is built on a hormone-first premise: fix your hormones and fix your eating. DeLuca’s work complicates that premise in ways worth sitting with.

    Take postpartum depression, where the hormonal framing is especially pervasive. Health websites and pregnancy guides almost universally attribute postpartum depression to the drop in reproductive hormones after delivery. DeLuca examines the research: comprehensive reviews over twenty years fail to show a clear causal link between hormonal changes and postpartum depression. The actual evidence-based predictors are social and structural:

    • Prior history of depression or mental illness (the strongest single predictor)
    • Inadequate social support
    • Unequal distribution of childcare and domestic labor
    • Relationship conflict
    • Financial stress
    • Inadequate maternity leave
    • The “motherhood mystique” (the belief that motherhood is natural and easy, which makes difficulty feel like personal failure)

    Hormones are not on that list as primary drivers. Telling a struggling new mother to balance her hormones is sending her toward an intervention the research does not support, while the actually modifiable factors go unaddressed. The same logic applies to eating. If what looks like a hormonal problem is actually a stress problem, a sleep problem, or a life-circumstances problem, no hormone protocol fixes it.

    DeLuca’s menopause research tells a similar story. Studies that gave women symptom checklists found symptoms (because that is what you measure when you only measure negative outcomes). Studies using open-ended methods found a consistent set of positive themes: relief from menstruation and contraception anxiety, increased assertiveness, clarity about what matters, a renewed sense of self-permission. Population-level data consistently shows that most menopausal women report good mental health and life satisfaction. Only 10-15% have symptoms severe enough to warrant treatment. The dominant narrative of menopause as catastrophic decline does not describe most women’s experience. It describes a minority’s experience and a pharmaceutical industry’s business model.

    None of this means hormonal conditions are not real or that no woman needs treatment. It means the relationship between hormones, mood, and eating behavior is considerably more nuanced than the hormone-optimization genre suggests. Reading DeLuca alongside books like Hormone Intelligence is the honest approach: take the real biology seriously without outsourcing the full explanation to biology.

    “Much of our cultural perception about menopause and aging in women was established, promoted, and maintained in order to make a profit. This is the ultimate abuse of our capacity for myth-making.” — Robyn Stein DeLuca

    Is The Hormone Myth Worth Reading?

    Read this if you have been consuming a lot of hormone-optimization content and want the skeptic’s counterpoint. If you have ever had your anger, exhaustion, or dissatisfaction attributed to your cycle when the person saying it was not interested in what you were actually responding to. If you are approaching perimenopause and the content you’re finding is alarming you in ways that feel disproportionate.

    Skip it if you are looking for treatment guidance. DeLuca tells you what to think about hormone claims, not what to do about your hormones. Those are different books, and this is firmly the former.

    One caveat: The book is a corrective argument, which means it sometimes leans hard in one direction to counter the weight on the other side. Readers with clinically significant PMDD or severe perimenopausal symptoms may occasionally feel their experience is being minimized rather than correctly contextualized. DeLuca is careful about this distinction in most chapters (PMDD is real, she says repeatedly; it affects a minority), but not always. Treat it as a calibration tool, not a verdict on your own experience.

    At 272 pages, it moves fast. The appendix on spotting junk science is worth the read on its own terms, a practical checklist for evaluating any health claim you encounter.

    Books Like The Hormone Myth

    BookAuthorBest For
    Hormone IntelligenceAviva RommThe affirmative counterpart: integrative medicine approach to actual hormone optimization
    It’s Your HormonesGeoffrey RedmondEndocrinologist’s clinical take on when hormone problems are genuinely the cause
    The Science of MenopauseJen Gunter & OthersEvidence-based menopause guidance that holds both the real biology and the cultural mythology
    Is It Me or My HormonesMarcelle PickIntegrative approach; useful to read alongside DeLuca for a fuller picture
    The Menopause ManifestoJen GunterOB/GYN takes apart menopause myths while honoring real symptoms; closest in spirit to DeLuca